Maravai LifeSciences Inc. (MRVI) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Maravai LifeSciences Inc... (MRVI)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

4.54

-0.39 (-8.00%)

At close: Jan 14, 2025, 3:59 PM

4.78

5.17%

After-hours Jan 14, 2025, 05:07 PM EST

undefined% (undefined)

Bid	4.47
Market Cap	644.68M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-1.67
PE Ratio (ttm)	-2.72
Forward PE	n/a
Analyst	Buy

Ask	4.98
Volume	1,894,221
Avg. Volume (20D)	1,947,800
Open	5.00
Previous Close	4.93
Day's Range	4.51 - 5.02
52-Week Range	4.28 - 11.55
Beta	undefined

About MRVI

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the productio...

[Show more]

Industry Biotechnology

Sector Healthcare

IPO Date Nov 20, 2020

Employees 580

Stock Exchange NASDAQ

Ticker Symbol MRVI

Website https://www.maravai.com

Analyst Forecast

According to 10 analyst ratings, the average rating for MRVI stock is "Buy." The 12-month stock price forecast is $10, which is an increase of 120.02% from the latest price.

Buy 50.00%

Hold 30.00%

Sell 10.00%

Stock Forecasts

Next Earnings Release

Maravai LifeSciences Inc. is scheduled to release its earnings on Feb 25, 2025, after market closes.
Analysts project revenue of $56.66M, reflecting a -23.58% YoY shrinking and earnings per share of -0.04, making a -500.00% decrease YoY.

Why Price Moved

2 months ago · Source

-35.2%

Maravai LifeSciences shares are trading lower afte... Unlock content with Pro Subscription

2 months ago · Source

-35.2%

Maravai LifeSciences shares are trading lower after William Blair downgraded the stock from Outperform to Market Perform and Baird cut its price target from $10 to $9.

News

2 months ago · seekingalpha.com

Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2024 Earnings Call Transcript

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI ) Q3 2024 Earnings Conference Call November 7, 2024 5:00 PM ET Company Participants Deb Hart - Head, Investor Relations Trey Martin - Chief Executive O...